Articles

Showing 6 articles

• Review

  Published 12 October 2026

  A review on advances in chemical compound toxicology prediction

  Ahmed Hagag · Nada A. Elsayed · Ibrahim Abdelbaky

  Frontiers in Bioinformatics

  doi 10.3389/fbinf.2026.1974935

• Original Research

  Published 4 September 2026

  Comparative in vitro safety assessments of synthetized and plant-derived cannabidiol (CBD), and pharmacokinetics of synthetized CBD: evidence of similar toxicological profiles and accumulation upon repeated oral administration

  E. T. Wong · D. Bovard · W. K. Schlage · W. Xia · H. Isa · O. Sirbu · A. R. Kolli · G. N. Nikolajsen · S. S. Jensen · J. Ho · B. Phillips · J. Hoeng

  Frontiers in Toxicology

  doi 10.3389/ftox.2026.1844643

• Original Research

  Published 18 August 2026

  Adverse drug events in hospitalized COVID-19 patients: a pharmacovigilance perspective on ICU management and fentanyl exposure

  Michele Ferreira Murgel · Marcel de Souza Borges Quintana · Roberta Olmo Pinheiro · Vítor Santos da Silva · Cláudia Luciana dos Santos Moura · Vanessa da Gama Oliveira · Cláudia Maria Valete Rosalino · Gilberto Marcelo Sperandio da Silva

  Frontiers in Epidemiology

  doi 10.3389/fepid.2026.1770145

• Original Research

  Published 21 May 2026

  A pilot study on therapeutic drug monitoring of asparaginase in Indian children with high-risk ALL: evidence for suboptimal exposure

  Himanshu Dhanda · Shamsuz Zaman · Bhavika Rishi · Raj Kamal · Manpreet Kaur · Nitika Anand · Baseer Noor · Pranay Tanwar · Sufian Zaheer · Prashant Prabhakar · Fouzia Siraj · Amitabh Singh · Aroonima Misra

  Frontiers in Hematology

  doi 10.3389/frhem.2026.1779396

• Original Research

  Published 15 May 2026

  Virtual screening and molecular dynamics simulations of cannabinoid receptor 2 agonists as drug candidates for osteoarthritis therapy

  Fernanda F. De Souza · Juliana F. Vilachã · Heberth De Paula · Kathia Maria Honorio

  Frontiers in Drug Discovery

  doi 10.3389/fddsv.2026.1809420

• Original Research

  Published 9 January 2026

  Hepatobiliary adverse drug reactions during treatment with olaparib: an analysis of data from the EudraVigilance reporting system

  Elena-Mirabela Velişcu · Cecilia Cagnotta · Maria Giuseppa Sullo · Antonietta Anatriello · Francesco Salvo · Cristina Scavone

  Frontiers in Drug Safety and Regulation

  doi 10.3389/fdsfr.2025.1736759